Durvalumab vs Tramadol

Durvalumab vs Tramadol: Overview

This comparison examines the pharmacological differences between Durvalumab and Tramadol.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Tramadol: Mu-opioid receptor agonist and serotonin-norepinephrine reuptake inhibitor.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Tramadol — 5-7 hours.

Chemical Properties

Molecular Formula: Tramadol — C16H25NO2.

Molecular Weight: Tramadol — 263.3750 g/mol.

Type: Durvalumab — Antibody; Tramadol — Small molecule.